撞擊症候群市場按類型、撞擊部位、患者年齡層、治療類型和地區分類

撞擊症候群市場規模預計在 2025 年達到 15.8 億美元，預計到 2032 年將達到 25.371 億美元，2025 年至 2032 年的年複合成長率為 7%。

撞擊症候群是指肩峰下間隙變窄，導致肩迴旋肌肌肉肌腱受到擠壓的一種疾病。肩袖肌腱在經過上臂頂端（肱骨）和肩峰之間時會受到擠壓。撞擊症候群的治療方法因撞擊嚴重程度而異，從簡單的家庭治療（例如服用阿斯匹靈和休息）到手術治療不等。撞擊肩迴旋肌，也稱為肩部撞擊，是指肩迴旋肌肌肉肌腱受到擠壓的疾病。當肌腱穿過肩部一個稱為肩峰下間隙的狹​​窄骨性間隙時，就會發生這種情況。當這些肌腱受到擠壓時，會引起疼痛和不適，尤其是在抬起手臂時。撞擊症候群可能是由重複的手臂運動或過頂活動引起的，這些活動會導致肩迴旋肌肌腱腫脹和發炎。撞擊症候群常見於涉及大量過頂動作的運動，例如網球、游泳和舉重，以及需要重複手臂動作的工作。撞擊症候群的症狀包括持續性肩部疼痛、夜間疼痛加劇以及難以伸手到背後。您也可能在舉起手臂或投球時感到疼痛。撞擊症候群的治療通常包括物理治療、非類固醇消炎劑(NSAID) 和皮質類固醇注射。嚴重病例可能需要手術。

市場動態：

肌肉骨骼疾病盛行率上升、老年人口成長、對安全有效治療的需求增加以及研發增加是預計推動全球撞擊症候群市場成長的關鍵因素。

例如，根據世界衛生組織（WHO）的數據，到2022年7月，全球約有17.1億人將患有肌肉骨骼疾病。肌肉骨骼疾病是全球殘疾的主要原因，其中腰痛是160個國家殘疾的主要原因。世衛組織推出「復健2030」舉措，以支持各國滿足現有的復健需求，包括肌肉骨骼疾病患者的復健需求，以及預計健康和人口趨勢將帶來的成長。

本研究的主要特點

• 本報告對全球撞擊綜合症市場進行了詳細分析，並給出了預測期（2025-2032）的市場規模和年複合成長率(CAGR)，假設 2024 年為基準年。
• 它還強調了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
• 該報告涵蓋了全球撞擊綜合症市場的主要企業概況，基於以下參數，例如公司亮點、產品系列、關鍵亮點、業績和策略。
• 本報告的見解可以幫助負責人和公司經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球撞擊綜合症市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
• 相關人員可以透過用於分析全球撞擊症候群市場的各種策略矩陣來更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
• 患病率不斷上升
• 提高認知和診斷
• 診斷技術的進步
  • 限制因素
• 治療費用高
• 有限退費政策
• 治療結果的差異
  • 機會
• 新的治療方法
• 病患教育與自我管理
• 遠端醫療和遠端監控
• 主要亮點
• 監管情景
• 近期動態
• 產品發布/核准
• PEST分析
• 波特分析
• 合併、收購和合作

4. 全球撞擊症候群市場-冠狀病毒（COVID-19）大流行的影響

• COVID-19流行病學
• 供需側分析
• 經濟影響

5. 2020 年至 2032 年全球撞擊症候群市場（按類型）

• 原發性撞擊症候群
• 繼發性撞擊症候群

6. 全球撞擊症候群市場（依撞擊部位分類），2020 年至 2032 年

• 肩膀
• 肩峰下
• 岡上肌腱和岡下肌腱
• 喙突
• 肩胛上神經
• 肩胛下肌腱
• 二頭肌肌腱
• 其他（肩迴旋肌症候群、肩肱關節撞擊等）

7. 2020 年至 2032 年按患者年齡族群分類的全球撞擊症候群市場

• 兒科（兒童和青少年）
• 成人（18-65歲）
• 老年人（65歲或以上）

8. 2020 年至 2032 年全球撞擊症候群市場（依治療類型）

• 藥品
• 物理治療
• 可的松注射
• 外科手術
• 替代治療
• 其他（矯正器具、輔助器具）

9. 2020 年至 2032 年按地區分類的全球撞擊症候群市場

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 中東和非洲
  • GCC
  • 以色列
  • 北非
  • 中部非洲
  • 其他中東和非洲地區

第10章 競爭格局

• 公司簡介
  • Johnson &Johnson（DePuy Synthes）
  • Medtronic plc
  • Breg, Inc.
  • CONMED Corporation
  • Ossur hf.
  • Colfax
  • Globus Medical, Inc.
  • Wright Medical Group NV
  • Arthrex, Inc.
  • Orthofix Medical Inc.
  • Bioventus LLC

第 11 章 章節

• 參考
• 調查方法
• 關於出版商

Impingement Syndrome Market is estimated to be valued at USD 1,580.0 Mn in 2025 and is expected to reach USD 2,537.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7% from 2025 to 2032.

Impingement syndrome refers to the narrowing of the subacromial space which leading to impingement of the tendons of the rotator cuff muscles. It is a condition in which the tendons of the rotator cuff of the shoulder are pinched as they pass between the top of the upper arm (humerus) and the tip of the shoulder (acromion). Impingement syndrome treatment can range from simple home treatment such as aspirin and rest to surgery, depending on how severe the impingement is. Impingement syndrome, also known as shoulder impingement, is a condition where the tendons of the rotator cuff muscles become compressed. This happens when these tendons pass through a narrow bony space in the shoulder called the subacromial space. The pressure on these tendons can cause pain and discomfort, especially when lifting the arm. Impingement syndrome can be caused by repetitive arm movements or overhead activities, which can lead to swelling and inflammation of the rotator cuff tendons. This is common in sports that require a lot of overhead movements like tennis, swimming, or weightlifting, and jobs that require repetitive arm movements. Symptoms of impingement syndrome include persistent pain in the shoulder, pain that worsens at night, and difficulty reaching up behind the back. Pain may also occur when lifting the arm overhead or while throwing a ball. Treatment for impingement syndrome often involves physical therapy, non-steroidal anti-inflammatory drugs (NSAIDs), and corticosteroid injections. In severe cases, surgery may be required.

Market Dynamics:

Increasing prevalence of musculoskeletal disorders, growing geriatric population, and rise in demand for safe & effective treatment, and increasing research and development are major factors expected to drive the growth of the global impingement syndrome market.

For instance, according to the World Health Organization (WHO), in July 2022, around 1.71 billion people across the globe worldwide have musculoskeletal conditions. Musculoskeletal conditions are the leading contributor to disability worldwide, with low back pain being the leading cause of disability in 160 countries. WHO has launched Rehabilitation 2030 Initiative to support countries to respond to existing rehabilitation needs, including people with musculoskeletal conditions, as well as the forecasted increase arising from health and demographic trends.

Key features of the study:

• This report provides in-depth analysis of the global impingement syndrome market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global impingement syndrome market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Johnson & Johnson (DePuy Synthes), Medtronic plc., Globus Medical, Inc., Wright Medical Group N.V., Arthrex, Inc., Colfax, Ossur hf., CONMED Corporation, Breg, Inc., Orthofix Medical Inc., and Bioventus LLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global impingement syndrome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global impingement syndrome market

Detailed Segmentation:

• By Type:
  • Primary Impingement Syndrome
  • Secondary Impingement Syndrome
• By Impingement Site:
  • Shoulder
  • Subacromial
  • Supraspinatus and Infraspinatus Tendon
  • Coracoid
  • Suprascapular Nerve
  • Subscapularis Tendon
  • Biceps Tendon
  • Others (Rotator cuff tendinitis, Glenohumeral joint impingement, etc.)
• By Patient Age Group:
  • Pediatric (children and adolescents)
  • Adult (18-65 years)
  • Geriatric (65+ years)
• By Treatment Type:
  • Medication
  • Physical Therapy
  • Cortisone Injections
  • Surgery
  • Alternative Treatment
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles
  • Johnson & Johnson (DePuy Synthes)
  • Medtronic plc.
  • Breg, Inc.
  • CONMED Corporation
  • Ossur hf.
  • DJO Global, Inc.
  • Globus Medical, Inc.
  • Wright Medical Group N.V.
  • Arthrex, Inc.
  • Orthofix Medical Inc.
  • Bioventus LLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Impingement Site
  • Market Snippet, By Patient Age Group
  • Market Snippet, By Treatment Type
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing prevalence
• Rising awareness and diagnosis
• Advancements in diagnostic technologies
  • Restraints
• High cost of treatment
• Limited reimbursement policies
• Variability in treatment outcomes
  • Opportunities
• New treatment modalities
• Patient education and self-management
• Telemedicine and remote monitoring
• Key Highlights
• Regulatory Scenario
• Recent Trends
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Global Impingement Syndrome Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Impingement Syndrome Market, By Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Primary Impingement Syndrome
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Secondary Impingement Syndrome
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Impingement Syndrome Market, By Impingement Site, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Shoulder
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Subacromial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Supraspinatus and Infraspinatus Tendon
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Coracoid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Suprascapular Nerve
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Subscapularis Tendon
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Biceps Tendon
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others (Rotator cuff tendinitis, Glenohumeral joint impingement, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Impingement Syndrome Market, By Patient Age Group, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pediatric (children and adolescents)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Adult (18-65 years)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Geriatric (65+ years)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Impingement Syndrome Market, By Treatment Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Medication
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Physical Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Cortisone Injections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Alternative Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others (Braces, Assistive devices)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

9. Global Impingement Syndrome Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Impingement Site, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Impingement Site, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Impingement Site, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Impingement Site, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Impingement Site, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • GCC
    • Israel
    • North Africa
    • Central Africa
    • Rest of Middle East & Africa

10. Competitive Landscape

• Company Profile
  • Johnson & Johnson (DePuy Synthes)
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Medtronic plc
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Breg, Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • CONMED Corporation
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Ossur hf.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Colfax
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Globus Medical, Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Wright Medical Group N.V.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Arthrex, Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Orthofix Medical Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Bioventus LLC
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Analyst Views

11. Section

• References
• Research Methodology
• About us